Xgeva gains NICE recommendation for bone metastasis
August 17, 2012Sales and Marketing Amgen, NICE, Xgeva, bone metastatis
NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …
Zaicom MMC appoints new medical writer
August 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine PeregrÃn, Zaicom MMC
Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine PeregrÃn as a medical writer. …
Novartis eye drug succeeds in Phase III trial
August 16, 2012Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA
Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …
Pfizer meets targets on greenhouse gases
August 16, 2012Manufacturing and Production GHGs, Merck, Pfizer
Pfizer says it has fulfilled its goal of cutting environmentally-harmful emissions from its facilities by 20%, a year ahead of …
The number one reason for a failed project
August 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Communication, Failed project, Les Rose, clinical trials
There was once a company that had an amusing form of words for admonishing people. It went something like this: …
Boehringer posts strong financials
August 16, 2012Sales and Marketing AMNOG, Boehringer, COPD, Spiriva
Boehringer Ingelheim has seen steady growth in the first half of 2012, but warns that the next six months may …
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka and Extensive Investments to Zydis® Technology Capabilities in Swindon, UK
August 16, 2012Manufacturing and Production
Somerset, NJ, July 24, 2012 – Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD …
Catalent and Bend Research Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies
August 16, 2012Manufacturing and Production
Catalent Pharma Solutions, Inc. and Bend Research Inc. have entered into an agreement to provide integrated solutions for pharmaceutical companies …
Diabetes prescriptions jump by 50% in England
August 15, 2012Sales and Marketing Humalog, Januvia, NHS, diabetes, spending
Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …
GSK sheds Australian generics unit for £172m
August 15, 2012Sales and Marketing Aspen Global, GSK, generics
GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …
Genus reprimanded for ‘sexual and titillating’ advert
August 15, 2012Sales and Marketing ABPI, Genus, PMCPA, breach, eczema
Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …
Smoke and fire in J&J Code breach
August 15, 2012Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer
Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …
MSD joins forces with PatientsLikeMe for psoriasis
August 14, 2012Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis
MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …
Elan to spin off drug discovery arm
August 14, 2012Research and Development, Sales and Marketing Elan, Neotype Biosciences, Tysabri, multiple sclerosis
Elan Corporation is to spin off its drug discovery arm Neotype Biosciences to create a separate, quoted company by the …
New Avastin data could be bad news for Lucentis
August 14, 2012Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD
The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …
China sets February 2013 deadline for excipient regulations
August 14, 2012Manufacturing and Production China, IPEC, SFDA, Taylor
China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …
Astellas Pharma Europe appoints new senior director
August 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood
Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …
Acino plant opens to serve Bayer contraceptive patch needs
August 14, 2012Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive
Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …
Novartis pledges to maintain R&D presence in Horsham
August 14, 2012Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts
Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
Pfizer pays $250m for OTC Nexium rights
August 14, 2012Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer
Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
